Page last updated: 2024-09-05

dabigatran and Acute Confusional Senile Dementia

dabigatran has been researched along with Acute Confusional Senile Dementia in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	8 (80.00)	24.3611
2020's	2 (20.00)	2.80

Authors

Authors	Studies
Ihara, M; Saito, S	1
Sharma, M	1
Callejas, S; Ceron, C; Cortes-Canteli, M; Fernandez-Nueda, I; Fuster, V; Ibanez, B; Jno-Charles, OC; Kruyer, A; Marcos-Diaz, A; Norris, EH; Richards, AT; Rodriguez, I; Ruiz-Cabello, J; Sanchez-Gonzalez, J; Strickland, S	1
Bihaqi, SW; Grammas, P; Iannucci, J; Sen, A; Vittal Rao, H	1
Grossmann, K	1
Alatawi, Y; Alghamdi, BS; Alshehri, FS; Balabagno, AO; Chen, Y; Durmanova, V; Evangelista, LS; Hromadka, T; Javor, J; Ji, Q; Jiao, J; Kralova, M; Kurdi, M; Labban, S; Li, X; Li, Y; Lv, Q; Minarik, G; Ocenasova, A; Pagsibigan, JS; Parnicka, Z; Reznakova, V; Shawkatova, I; Shen, ZJ; Tian, X; Tu, S; Tuazon, JA; Vaseckova, B; Wang, XY; Wang, Z; Xue, Y; Zeng, LX; Zhang, S; Zhang, ZH; Zuo, C	1
Cipriano, LE; Hachinski, V; Lee, SAW; Ruiz Vargas, E; Sposato, LA	1
Bachellerie, B; Conil, JM; Crognier, L; Fourcade, O; Georges, B; Ruiz, S; Seguin, T	1
Braun, D; Feinstein, DL; Givogri, MI; Kalinin, S; Marangoni, MN; Moyano, AL; Polak, P; Situ, A	1
Rami, BK	1

Reviews

1 review(s) available for dabigatran and Acute Confusional Senile Dementia

Article	Year
Alzheimer's Disease-Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran. International journal of molecular sciences, 2021, Apr-30, Volume: 22, Issue:9 Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antithrombins; Dabigatran; Fibrin; Hemostasis; Humans; Thrombin	2021

Other Studies

9 other study(ies) available for dabigatran and Acute Confusional Senile Dementia

Article	Year
[Drug Repositioning for Alzheimer's Disease]. Brain and nerve = Shinkei kenkyu no shinpo, 2019, Volume: 71, Issue:9 Topics: Alzheimer Disease; Cilostazol; Dabigatran; Drug Repositioning; Humans; Insulin; Probucol; Telmisartan	2019
Preventing Alzheimer's Disease: Some Light in the Darkness. Journal of the American College of Cardiology, 2019, 10-15, Volume: 74, Issue:15 Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cognitive Dysfunction; Dabigatran; Humans; Mice; Time-to-Treatment	2019
Long-Term Dabigatran Treatment Delays Alzheimer's Disease Pathogenesis in the TgCRND8 Mouse Model. Journal of the American College of Cardiology, 2019, 10-15, Volume: 74, Issue:15 Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Anticoagulants; Blood-Brain Barrier; Cerebral Cortex; Dabigatran; Disease Models, Animal; Female; Fibrin; Hemostasis; Hippocampus; Maze Learning; Memory; Mice; Mice, Transgenic; Neurodegenerative Diseases; Perfusion; Thrombosis	2019
Thrombin Signaling Contributes to High Glucose-Induced Injury of Human Brain Microvascular Endothelial Cells. Journal of Alzheimer's disease : JAD, 2021, Volume: 79, Issue:1 Topics: Alzheimer Disease; Antithrombins; Brain; Cyclic AMP Response Element-Binding Protein; Dabigatran; Diabetes Mellitus, Type 2; Endothelial Cells; Endothelium, Vascular; Glucose; Humans; Inflammation; Interleukin-6; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Microvessels; NADPH Oxidase 4; Nitric Oxide Synthase Type II; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Thrombin; Tumor Necrosis Factor-alpha; Up-Regulation	2021
Acta medica Philippina, 2017, Volume: 51, Issue:4 Topics: Administration, Oral; Aged; Aged, 80 and over; Alzheimer Disease; Angiotensin II; Animals; Antithrombins; Atrial Fibrillation; Body Mass Index; Catheter Ablation; Cohort Studies; Dabigatran; Dogs; Embolism; Factor Xa Inhibitors; Female; Genotype; Hemorrhage; Humans; Hypertension; Hypertrophy, Left Ventricular; Incidence; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 3; Middle Aged; Norepinephrine; Obesity; Polymorphism, Single Nucleotide; Retrospective Studies; Rivaroxaban; Stroke; Sympathectomy	2017
Anticoagulation Therapy for Atrial Fibrillation in Patients With Alzheimer's Disease. Stroke, 2018, Volume: 49, Issue:12 Topics: Aged; Alzheimer Disease; Anticoagulants; Atrial Fibrillation; Cost-Benefit Analysis; Dabigatran; Disease Progression; Health Care Costs; Humans; Pyrazoles; Pyridines; Pyridones; Quality-Adjusted Life Years; Rivaroxaban; Stroke; Thiazoles; Warfarin	2018
[Patient with acute renal injury presenting dabigatran overdose: Hemodialysis for surgery]. Annales francaises d'anesthesie et de reanimation, 2014, Volume: 33, Issue:1 Topics: Acute Kidney Injury; Aged, 80 and over; Alzheimer Disease; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation Disorders; Dabigatran; Diabetes Mellitus, Type 2; Drug Overdose; Hemorrhage; Humans; Hyperkalemia; Male; Neoplasms; Phlebitis; Renal Dialysis	2014
Differential effects on glial activation by a direct versus an indirect thrombin inhibitor. Journal of neuroimmunology, 2016, 08-15, Volume: 297 Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Anticoagulants; Brain; Calcium-Binding Proteins; Dabigatran; Disease Models, Animal; Female; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microfilament Proteins; Mutation; Neuroglia; Peptide Fragments; Presenilin-1; Warfarin	2016
Direct thrombin inhibitors' potential efficacy in Alzheimer's disease. American journal of Alzheimer's disease and other dementias, 2012, Volume: 27, Issue:8 Topics: Aged; Alzheimer Disease; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Cardiovascular Diseases; Dabigatran; Endothelium, Vascular; Heparin; Humans; Thrombin	2012